Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1
"Tariffs will be a headwind," Solventum's CEO said Thursday, after the company boosted its sales forecast for 2025 — but not its bottom-line forecast. "Without them, we would be raising our EPS guidance commensurate with the underlying momentum we’re seeing in the business."
"Tariffs will be a headwind," Solventum's CEO said Thursday, after the company boosted its sales forecast for 2025 — but not its bottom-line forecast. "Without them, we would be raising our EPS guidance commensurate with the underlying momentum we’re seeing in the business." 
